ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Voyager Therapeutics Inc

Voyager Therapeutics Inc (VYGR)

5,67
-0,08
(-1,39%)
Fermé 27 Novembre 10:00PM
5,62
-0,05
(-0,88%)
Après les heures de négociation: 12:48AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
5,62
Prix Achat
5,54
Prix Vente
5,99
Volume échangé
271 041
5,54 Fourchette du Jour 5,80
5,19 Plage de 52 semaines 11,72
Cap du marché
Clôture Veille
5,75
Ouverture
5,80
Dernière Transaction
32
@
5.78
Dernière heure de transaction
Volume financier
US$ 1 527 313
VWAP
5,635
Volume moyen (3 m)
573 768
Actions en circulation
54 625 586
Rendement du Dividende
-
Ratio Cours sur Bénéfices
2,34
Bénéfice par action (BPA)
2,42
Chiffre d'affairess
250,01M
Bénéfice net
132,33M

À propos de Voyager Therapeutics Inc

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the produc... Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. The company operates in a single segment of developing and commercializing gene therapies. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Siège social
Wilmington, Delaware, USA
Fondé
-
Voyager Therapeutics Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker VYGR. Le dernier cours de clôture d'Voyager Therapeutics était de US$5,75. Au cours de la dernière année, les actions de Voyager Therapeutics ont été négociées dans une fourchette de prix de US$ 5,19 à US$ 11,72.

Voyager Therapeutics compte actuellement 54 625 586 actions en circulation. La capitalisation boursière d'Voyager Therapeutics est de US$314,10 million. Voyager Therapeutics a un ratio cours/bénéfice (ratio PE) de 2.34.

VYGR Dernières nouvelles

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease

- Candidate VY1706 demonstrates significant reductions of tau at low doses in NHP study; IND and CTA filings anticipated in 2026 - - VY1706 is the fifth neuro gene therapy development candidate...

Voyager Reports Third Quarter 2024 Financial and Operating Results

- Enrollment and dosing complete in single ascending dose clinical trial of anti-tau antibody VY7523 for Alzheimer’s; on track to generate top-line data H1 2025 - - Recent third-party clinical...

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

LEXINGTON, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the...

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast

LEXINGTON, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will...

Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected

LEXINGTON, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.254.655493482315.375.925.194604655.44948369CS
4-1.32-19.02017291076.947.435.195687856.42233248CS
12-0.94-14.32926829276.568.2755.195737686.52200462CS
26-2.69-32.37063778588.319.555.194935577.14542326CS
52-1.21-17.71595900446.8311.725.195899758.09301764CS
1562.5583.06188925083.0714.33982.544593577.83014069CS
260-8.42-59.971509971514.0415.262.466932226.46523779CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
PSTXPoseida Therapeutics Inc
US$ 9,38
(227,97%)
29,42M
IMGCIMG Inc
US$ 1,615
(156,35%)
114,46M
IDAIT Stamp Inc
US$ 0,364
(102,22%)
549,04M
PGHLPrimega Group Holdings Ltd
US$ 20,95
(98,77%)
2,77M
TOYOTOYO Company Ltd
US$ 5,41
(86,55%)
48,64M
ALECAlector Inc
US$ 2,575
(-34,97%)
7,94M
ABVEAbove Food Ingredients Inc
US$ 0,5338
(-34,42%)
1,65M
LGCLLucas GC Ltd
US$ 0,7511
(-33,53%)
2,48M
ADDColor Star Technology Company Ltd
US$ 4,19
(-31,87%)
204,17k
LESLLeslies Inc
US$ 2,445
(-30,34%)
24,38M
IDAIT Stamp Inc
US$ 0,364
(102,22%)
560,18M
ELABElevai Labs Inc
US$ 0,01255
(-21,07%)
325,82M
NVDANVIDIA Corporation
US$ 136,92
(0,66%)
190,3M
RGTIRigetti Computing Inc
US$ 2,195
(-20,18%)
126,72M
IMGCIMG Inc
US$ 1,615
(156,35%)
114,51M
Aucune Discussion Trouvée
Ajouter une Discussion